Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
29 mars 2024 06h15 HE
|
Guardion Health Sciences, Inc.
Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 ...
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.
30 janv. 2024 18h13 HE
|
Guardion Health Sciences, Inc.
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell...
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
13 nov. 2023 16h10 HE
|
Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022 HOUSTON, TEXAS, Nov. ...
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
14 août 2023 08h15 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer
30 mai 2023 08h00 HE
|
Guardion Health Sciences, Inc.
HOUSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023
15 mai 2023 08h15 HE
|
Guardion Health Sciences, Inc.
HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022
17 avr. 2023 08h15 HE
|
Guardion Health Sciences, Inc.
HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value
06 mars 2023 08h00 HE
|
Guardion Health Sciences, Inc.
HOUSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
24 janv. 2023 16h05 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock Market...
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
06 janv. 2023 16h15 HE
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its common...